Market Access
European Commission approves Johnson & Johnson’s Crohn’s disease therapy
May 12, 2025 Market Access, Research and Development, Sales and Marketing Crohn’s disease, European Commission, Gastrointestinal tract, Johnson & Johnson, guselkumab, marketing authorisation
The European Commission (EC) has granted Marketing Authorisation (MA) to Johnson & Johnson’s Tremfya (guselkumab) for the treatment of moderately …
EU approval granted for rare kidney disease treatment
April 29, 2025 Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology
The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
Nordic Pharma’s Lacrifill canalicular gel gains CE mark approval and set for European launch
April 14, 2025 Market Access, Research and Development, Sales and Marketing Nordic Pharma, Opthalmology, dry eye disease
International pharma company Nordic Pharma has announced that its Lacrifill treatment for dry eye disease has received European Conformity (CE) …
FDA approves Pfizer’s pneumococcal conjugate vaccine for infants and children
April 28, 2023 Market Access, Research and Development, Sales and Marketing Ear Nose & throat, FDA, Immunology, Pfizer, Vaccine, pneumococcal vaccine
Pfizer has announced that the US Food and Drug Administration (FDA) has approved its PREVNAR 20 (20-valent pneumococcal conjugate vaccine) …
